Clinical observation of post-stroke depression by Buspirone combined with Escitalopram
Hongyan Yu
Abstract
Hongyan Yu
Abstract
Objective:To compare the effect and safety of Buspirone combined with Escitalopram and Escitalopram used singly in the treatment of post-stroke depression.Methods:Totally the 60 post-stroke depression patients were randomized into control group(n=30),treated with Escitalopram,and study group(n=30),treated by Buspirone combined with Escitalopram.The observation lasted 8 weeks.The therapeutic effect and safety were evaluated by the positive and negative syndrome scale of HAMD(24 items),and treatment emergent symptom scale of TESS.Results:Total effective rate of the study group was 93.3%(28/30) and with the control group 63.3%(23/30),there was a significant difference(χ2=8.91,P=0.031,P0.05),and according to HAMD total scores assessment,there was a significant difference between two groups(P0.05) after the treatment in different weekend.The difference of TESS scores between two groups was not significant.Conclusion:Buspirone combined with Escitalopram is effective and safe in the treatment of post-stroke depression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the effect and safety of Buspirone combined with Escitalopram and Escitalopram used singly in the treatment of post-stroke depression.Methods:Totally the 60 post-stroke depression patients were randomized into control group(n=30),treated with Escitalopram,and study group(n=30),treated by Buspirone combined with Escitalopram.The observation lasted 8 weeks.The therapeutic effect and safety were evaluated by the positive and negative syndrome scale of HAMD(24 items),and treatment emergent symptom scale of TESS.Results:Total effective rate of the study group was 93.3%(28/30) and with the control group 63.3%(23/30),there was a significant difference(χ2=8.91,P=0.031,P0.05),and according to HAMD total scores assessment,there was a significant difference between two groups(P0.05) after the treatment in different weekend.The difference of TESS scores between two groups was not significant.Conclusion:Buspirone combined with Escitalopram is effective and safe in the treatment of post-stroke depression.
Key concepts: Escitalopram, Buspirone, Hamd, Medicine, Post-stroke depression, Depression (economics), Significant difference, Citalopram